Showing 381-390 of 695 results for "".
The Ten Commandments of COVID
https://modernaesthetics.com/topics/practice-development/the-ten-commandments-of-covid/34891/Pearls from the Experts
https://modernaesthetics.com/ma-supplements/2018-mar-apr-supplement/pearls-from-the-experts/34169/Tips from Solta device users.Here Comes the Judge
https://modernaesthetics.com/ma-issues-index/2018-mar-apr/here-comes-the-judge/34142/Interoperability Update
https://modernaesthetics.com/ma-issues-index/2017-may-june/interoperability-update/34272/Are PHRs the key to interoperability?New in My Practice: Devices
https://modernaesthetics.com/ma-issues-index/2014-july-aug/new-in-my-practice-devices/34608/A Cosmetic Surgery Boom
https://modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/a-cosmetic-surgery-boom/33930/New data from the American Society of Plastic Surgeons show business is good for aesthetic physicians. In fact, more than three-quarters of cosmetic-focused plastic surgery practices are seeing more business than before the pandemic. Bob Basu, MD, a plastic surgeon in Houston, TX, discusses the tMATV News: ASPS Stats, Upneeq Eyedrops for Ptosis; Allergan Acquires Soliton; The Beauty Health Company
https://modernaesthetics.com/series/matv-news/matv-news-asps-stats-upneeq-eyedrops-for-ptosis-allergan-acquires-soliton-the-beauty-health-company/33633/Annual statistics from the American Society of Plastic Surgeons predict an increased demand for cosmetic plastic surgery and non-surgical procedures and Wendy Lee, MD discusses the role for RVL’s Upneeq, a non-surgical option for ptosis, in aesthetic practices. Plus, Allergan Aesthetics acquires SolMATV News: COVID-19 Vaccine & Fillers; Allergan Aesthetics Could Acquire Cypris; Merz + Candela Partner to Expand Portfolio; New ASDS Stats
https://modernaesthetics.com/series/matv-news/matv-news-covid-19-vaccine-fillers-allergan-aesthetics-could-acquire-cypris-merz-candela-partner-to-expand-portfolio-new-asds-stats/33623/MATV News: Aesthetics experts weigh in on COVID-19 vaccine side effects in dermal filler patients, Allergan Aesthetics enters into option to acquire Cypris Medical and its Xact tool, Merz Aesthetics and Candela partner, to offer broad aesthetics portfolio, and new ASDS survey data show cosmetic procComing & Going: November/December 2020
https://modernaesthetics.com/ma-issues-index/2020-nov-dec/coming-going-novemberdecember-2020/34979/Coming & Going
https://modernaesthetics.com/topics/skincare/coming-going/33963/